Literature DB >> 31676268

The Molecular Interaction Process.

Thomas M Laue1, Steven J Shire2.   

Abstract

Noncovalent molecular interactions, which are central to life, are thermodynamic processes that follow common interaction pathways. This commentary provides a foundation for both considering noncovalent interactions and the interplay between the protein properties and the solvent properties in determining the energetics. In biopharmaceutics, noncovalent interactions are a 2-edged sword. Foremost, they provide a core function for biopharmaceutical agents, binding to targets, substrates, or receptors. At the same time, they are at the root of the solubility and viscosity difficulties encountered in the manufacture, formulation, and delivery of protein-based pharmaceuticals. This commentary describes the interaction process and summarizes the energetics of the interaction pathway. The focus will be on protein-protein interactions, while recognizing that the processes and energetics are entirely general and applicable to all solution interactions. The contributions of protein molecular properties and protein colloidal properties to the pathway are described, and the relationship between the two is developed. The processes leading to protein-protein binding are described with respect to the attractive interactions that lead to aggregation and high viscosity. The concept of emergent heterogeneity is introduced, and a model presented for how noncontacting interactions may lead to high viscosities without simultaneously causing low solubility.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Keywords:  aggregation; binding; binding mechanism; colloidal stability; molecular interactions; molecular stability; physical stability; protein-protein-interactions; viscosity

Year:  2019        PMID: 31676268     DOI: 10.1016/j.xphs.2019.10.045

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Use of Debye-Hückel-Henry charge measurements in early antibody development elucidates effects of non-specific association.

Authors:  Joshua R Laber; Thomas M Laue; Dana I Filoti
Journal:  Antib Ther       Date:  2022-07-28

2.  Toward Biotherapeutics Formulation Composition Engineering using Site-Identification by Ligand Competitive Saturation (SILCS).

Authors:  Sandeep Somani; Sunhwan Jo; Renuka Thirumangalathu; Danika Rodrigues; Laura M Tanenbaum; Ketan Amin; Alexander D MacKerell; Santosh V Thakkar
Journal:  J Pharm Sci       Date:  2020-11-01       Impact factor: 3.784

3.  Analysis of nonideality: insights from high concentration simulations of sedimentation velocity data.

Authors:  J J Correia; R T Wright; P J Sherwood; W F Stafford
Journal:  Eur Biophys J       Date:  2020-11-06       Impact factor: 1.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.